- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/68 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Patent holdings for IPC class A61K 47/68
Total number of patents in this class: 12279
10-year publication summary
234
|
473
|
831
|
1002
|
962
|
1136
|
1187
|
1317
|
1507
|
1165
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
SeaGen Inc | 590 |
257 |
Daiichi Sankyo Company, Limited | 1886 |
208 |
Regeneron Pharmaceuticals, Inc. | 4312 |
203 |
Genentech, Inc. | 3988 |
193 |
MedImmune Limited | 617 |
151 |
Hanmi Pharm. Co., Ltd. | 574 |
148 |
Dyne Therapeutics, Inc. | 247 |
135 |
ImmunoGen, Inc. | 399 |
134 |
The Regents of the University of California | 20035 |
113 |
Bristol-myers Squibb Company | 4867 |
94 |
Novartis AG | 10726 |
91 |
Bolt Biotherapeutics, Inc. | 119 |
89 |
Pfizer Inc. | 3364 |
78 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 294 |
77 |
ADC Therapeutics SA | 122 |
65 |
Zymeworks Inc. | 261 |
65 |
Hoffmann-La Roche Inc. | 3456 |
63 |
CytomX Therapeutics, Inc. | 223 |
60 |
Memorial Sloan-Kettering Cancer Center | 1940 |
60 |
Yale University | 2400 |
60 |
Other owners | 9935 |